logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yi‐Long Wu

guangdong academy of medical sciences
H指数:135
被引数:11.1万
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SUNRAY-02: a study of olomorasib combined with immunotherapy in stage II-III KRAS G12C-mutant non-small cell lung cancer after definitive therapy

SUNRAY-02：奥莫罗西比与免疫疗法联合治疗经根治性治疗后处于II-III期KRAS G12C突变型非小细胞肺癌的研究

Future Oncology
IF2.6
2026-10-010
OA
Jamie Chaft; Jay M. Lee; Suresh Senan; Joel W. Neal; Ernest Nadal; Marcelo V. Negrao; Sanjay Popat; Marina C. Garassino; Jhanelle E. Gray; Se-Hoon Lee; Julien Mazieres; Michael Thomas; Martin Benes; Hui Liu; Jian Liu; Qinli Lily Ma; Grace Segall; Tarun Puri; Yi-Long Wu
Pseudoprogression in neoadjuvant immunotherapy for resectable NSCLC: a PET–CT-based study

可切除非小细胞肺癌新辅助免疫治疗中的假性进展：一项基于PET–CT的研究

ESMO Open
IF8.3
2026-09-080
OA
Y. Pan; J. Chen; H. Lin; L.-B. Tang; H.-H. Yan; J.-X. Zeng; S. Dong; L.-X. Yan; Y. Yang; D.-J. Li; Y.-L. Wu
FUS inactivation promotes leptomeningeal metastasis of lung cancer through the up-regulation of CD36

FUS失活通过上调CD36促进肺癌的脑膜转移

Science Translational Medicine
IF14.6
2026-08-260
PRE
Shouheng Lin; Kai Yin; Mei-Mei Zheng; Hai-Yan Tu; Wanjun Li; Zhiping Wu; Diwei Zheng; Youguo Long; Qiting Wu; Duo Li; Xiwei Wang; Xichen Bao; Yao Yao; Ziyuan Duan; Georgia Carson; Ben-Yuan Jiang; Lu Zeng; Zhi-Hong Chen; Qing Zhou; Jin-Ji Yang; Wen-Zhao Zhong; Xu-Chao Zhang; Hua-Jun Chen; Bin-Chao Wang; Fa-Man Xiao; Si-Yang Maggie Liu; Li-Xu Yan; Jean Paul Thiery; Yang-Si Li; Yi-Long Wu; Peng Li
Adjuvant alectinib versus chemotherapy in resected ALK- positive non-small-cell lung cancer (ALINA): health-related quality-of-life and safety outcomes from a randomised, open-label, phase 3 trial

辅助阿来替尼与化疗在切除后的ALK阳性非小细胞肺癌（ALINA）：一项随机、开放标签、III期试验的健康相关生活质量与安全性结果

Lancet Oncology
IF35.9
2026-08-010
OAAI
Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Solomon, Benjamin J.; Wu, Yi-Long; Bondarenko, Igor; Hochmair, Maximilian; Horinouchi, Hidehito; Lee, Dae Ho; Lee, Jong-Seok; Planchard, David; Rittmeyer, Achim; Zhong, Wenzhao; Adler, Leah; Archer, Venice; Cardona, Andres; Petric, Patricia; Scalori, Astrid; Ding, Beiying; Mamolo, Carla; Smoljanovic, Vlatka; Nishio, Makoto
Neoadjuvant retlirafusp alfa (anti-PD-L1/TGF-β bifunctional fusion protein) with or without chemotherapy in unresectable stage III non-small cell lung cancer: updated results from the phase 2 TRAILBLAZER trial

在不可切除的III期非小细胞肺癌中进行或不进行化疗的新辅助retlrafusp alfa (anti-PD-L1/tgf-β 双功能融合蛋白): 来自2期开拓者试验的更新结果

Signal Transduction and Targeted Therapy
IF52.7
2026-06-160
OA
Yi Pan; Xuening Yang; Qing Zhou; Yanqiu Zhao; Guang Han; Qingsong Pang; Zhenfa Zhang; Qifeng Wang; Jun Yao; Hui Wang; Weihua Yang; Baogang Liu; Qixun Chen; Xianghui Du; Kaican Cai; Baosheng Li; Yunchao Huang; Xiao Li; Yijun Jia; Li Song; Wei Shi; Yi-Long Wu
Circulating tumor DNA analysis in lung cancer: from molecular origins to analytical boundaries

肺癌循环肿瘤DNA分析：从分子起源到分析界限

Lung Cancer
IF4.4
2026-05-290
OAAI
Jia-Tao Zhang; Bai-Xin Lin; Xin-Guang Zhao; Wen-Zhao Zhong; Yi-Long Wu
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer

基于NGS的MET扩增评估中基因拷贝数阈值的探索性识别及在非小细胞肺癌中与MET抑制剂疗效的临床相关性

lung cancer: targets and therapy
IF0
2026-05-080
OAAI
Si-Yang Maggie Liu; Zhi Xie; Lixu Yan; Guang-Ling Jie; Jia-Yi Deng; Qingling Zhang; Zhan Huang; Jin Wang; Zhou Zhang; Yang Shao; Hao Meng; Yan Zhang; Xu-Chao Zhang; Hua-Jun Chen; Wen-Zhao Zhong; Qing Zhou; Yi-Long Wu
Treatments for Human epidermal growth factor receptor 2 (HER2)–Altered cancers evaluated using a tumor‑agnostic approach: A narrative review

针对人类表皮生长因子受体2（HER2）变异癌症的治疗方法：基于肿瘤非特异方法的叙述性综述

Cancer Treatment Reviews
IF10.5
2026-04-170
OAAI
Guilherme Harada; Jamie E. Chaft; Alison M. Schram; Nick Pavlakis; Yi-Long Wu
Cardiovascular adverse events in non-small cell lung cancer patients receiving osimertinib therapy: a systematic review and meta-analysis

非小细胞肺癌患者接受奥希替尼治疗的心血管不良事件：一项系统评价和荟萃分析

Lung Cancer
IF4.4
2026-04-150
PRE
Wei-He Liu; Yun-Jiu Cheng; Jin Kang; Jian Chen; Zhen-Jie An; Ting-Hui Li; Ning Tan; Wen-Zhao Zhong; Yi-Long Wu; Lei Jiang
Gotistobart or docetaxel in metastatic squamous non-small cell lung cancer: stage 1 of the randomized phase 3 PRESERVE-003 trial

在转移性鳞状非小细胞肺癌中使用clotistobart或多西他赛: 随机3期PRESERVE-003试验的1期

Nature Medicine
IF50
2026-03-270
OAAI
Byoung Chul Cho; Rama Balaraman; Hua-Jun Chen; Xinmin Yu; Adewale Fawole; Zhi-gang Liu; Jiliang Zhang; Long Wu; Bin Yang; Jennifer L. Leddon; John Hamm; Yanjing Huang; Lin Wu; Pinhua Pan; Preet Singh; Andrew Beardsley; Fadi Kayali; Ardalan Davarifar; Ki Hyeong Lee; Keon-Uk Park; Youngjoo Lee; Luchun Li; Xicheng Wang; Meili Sun; Yan Yu; Vikram Jain; Svetlana Shpyro; Qiong Wang; Michael Wenger; Uğur Şahin; Sergey Efuni; Shiling Song; Kun He; Pan Zheng; Yang Liu; Kai He; Tianhong Li; Mark A. Socinski; Yi-Long Wu
Response to Letter to the Editor: “Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicability”

对致编辑的信的回应: “改善NSCLC和脑转移患者的免疫放化疗: 生物标志物，神经保护和全球适用性的见解”

Journal of Thoracic Oncology
IF20.8
2026-02-040
PRE
Yang-Si Li; Jin-Ji Yang; Yi-Long Wu
Plain language summary of the ALINA study results: alectinib compared with chemotherapy after surgery in people with ALK-positive non-small cell lung cancer

ALINA研究结果的大众语言摘要：alectinib与化疗相比，在ALK阳性非小细胞肺癌患者术后的应用

Future Science OA
IF2.1
2025-12-310
PRE
Wu, Yi-Long; Dziadziuszko, Rafal; Ahn, Jin Seok; Barlesi, Fabrice; Nishio, Makoto; Lee, Dae Ho; Lee, Jong-Seok; Zhong, Wenzhao; Horinouchi, Hidehito; Mao, Weimin; Hochmair, Maximilian; De Marinis, Filippo; Migliorino, Maria Rita; Bondarenko, Igor; Lu, Shun; Wang, Qun; Lohmann, Tania Ochi; Xu, Tingting; Cardona, Andres; Hiles, Laura; Noe, Johannes; Solomon, Benjamin J.
Comparison of survival outcomes between sublobar resection and lobectomy in pathological stage IA pulmonary invasive mucinous adenocarcinoma

比较亚肺叶切除与肺叶切除术在病理分期IA期肺浸润性黏液腺癌中的生存结局

Asian Journal of Surgery
IF3.8
2025-12-130
OAAI
Zhen-Bin Qiu; Hong-Ji Li; Jia-Yan Ding; Chao Zhang; Jin-Hai Yan; Fang-Ping Xu; Yi-Long Wu; Wen-Zhao Zhong; Ben-Yuan Jiang
Tradeoff Between Information Premium and Institutional Friction: New Evidence from Regularized Government Accounting Supervision in China

信息溢价与制度摩擦之间的权衡：来自中国常规化政府会计监督的新证据

The British Accounting Review
IF0
2025-12-070
PRE
Tianquan Jin; Xiumei Liu; Yilong Wu; Ziheng Xie
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapy

PACIFIC-5: 在不可切除的III期NSCLC患者中巩固durvalumab的III期临床试验，同时或序贯放化疗后无进展

Journal of Hematology & Oncology
IF40.4
2025-12-070
OAAI
Yi-Long Wu; Lin Wu; Nan Bi; Timucin Cil; Hong Ge; Zhengfei Zhu; Chih-Liang Wang; Wei Zhang; Dongqing Lv; E. Mingyan; Jianguo Sun; Yi Pan; Maciej Krzakowski; Mustafa Dikilitas; Mehmet Ali Nahit Sendur; Young-Chul Kim; Yanjiao Yang; Rui Mao; Biao Zhang; Luhua Wang
Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study

Vebreltinib治疗MET扩增驱动型晚期非小细胞肺癌（KUNPENG研究）：一项单臂、多队列、多中心、Ⅱ期研究

The Lancet Oncology
IF0
2025-12-060
PRE
Yi-Long Wu; Yu Yao; Jin-Ji Yang; Lin Wu; Wei Zhang; Ying Wang; Hai-Peng Xu; Yong Song; Yan Zhang; Jun Zhao; Jing-Hua Chen; Zhe-Hai Wang; Qi-Ming Wang; Jie Hu; Xing-Ya Li; Yun Fan; Yuan Chen; Jian Fang; Di Han; Wei-Zhe Xue
Five-year outcomes of pembrolizumab versus chemotherapy in Chinese patients with non-small-cell lung cancer and programmed cell death ligand 1 tumor proportion score ≥1%: KEYNOTE-042 China study

pembrolizumab与化疗在中国非小细胞肺癌和程序性细胞死亡配体1肿瘤比例评分 ≥ 1% 的患者中的五年结果: KEYNOTE-042中国研究

INTERNATIONAL JOURNAL OF CANCER
IF4.7
2025-12-010
OAAI
Wu, Yi-Long; Zhang, Li; Fan, Yun; Zhou, Jianying; Zhou, Qing; Li, Wei; Hu, Chengping; Chen, Gongyan; Zhang, Xin; Zhou, Caicun; Arenas, Carmen Gonzalez; Chen, Zhenghong; Yu, Wen Cheng; Mok, Tony S. K.
Real-world use of and clinical outcomes with dacomitinib as first-line therapy in Asian patients with EGFR mutation–positive locally advanced or metastatic non-small cell lung cancer: Final analysis of the ARIA study

达可替尼作为亚洲表皮生长因子受体（EGFR）突变阳性局部晚期或转移性非小细胞肺癌患者的一线疗法：ARIA研究的最终分析

Lung Cancer
IF4.4
2025-11-250
PRE
Lin Wu; Junling Li; Chong-Rui Xu; Bivas Biswas; Somnath Roy; Ke-Jing Tang; Huijuan Wang; Ziling Liu; Ullas Batra; Gwo Fuang Ho; John Low Seng Hooi; You Lu; Mingfang Zhao; Lye Mun Tho; Jun Zhao; Shan He; Joan Huang; Hui Zhang; Chew Hooi Wong; Yi-Long Wu
Proton activated chloride channel and its regulation of insulin secretion in β cells

质子激活的氯离子通道及其对β细胞胰岛素分泌的调控

The International Journal of Biochemistry & Cell Biology
IF0
2025-11-180
OAAI
Yi Wu; Fang Wang; Fang-Lin Peng
Ginsenoside Rb3 prevents myocardial injury in sleep-deprived mice by suppressing ferroptosis through SIRT3/P53/SLC7A11/GPX4 axis
FOOD SCIENCE AND HUMAN WELLNESS
IF7.4
2025-11-010
PRE
Wu, Yi; Miao, Yuping; Huang, Xuanxuan; Cao, Yin; Wang, Zhengtao; Wu, Xiaojun

研究方向

暂未获取到该数据
周
周清
H 指数:58论文数:532被引数:1.6万
钟
钟文昭
H 指数:58论文数:527被引数:1.2万
T
Tony Mok
H 指数:131论文数:1,091被引数:10.6万
X
Xu‐Chao Zhang
H 指数:49论文数:299被引数:9,024
J
Jin‐Ji Yang
H 指数:50论文数:296被引数:8,847
H
Hong‐Hong Yan
H 指数:40论文数:248被引数:7,427
H
Hai‐Yan Tu
H 指数:36论文数:292被引数:6,441
苏剑 封面图
苏剑
H 指数:48论文数:277被引数:8,091
S
Si‐Yang Maggie Liu
H 指数:30论文数:204被引数:4,461
C
Chong‐Rui Xu
H 指数:36论文数:284被引数:7,268